This website uses cookies for anonymised analytics and for account authentication. See our privacy and cookies policies for more information.





The voice of Scotland’s vibrant voluntary sector

Published by Scottish Council for Voluntary Organisations

TFN is published by the Scottish Council for Voluntary Organisations, Mansfield Traquair Centre, 15 Mansfield Place, Edinburgh, EH3 6BB. The Scottish Council for Voluntary Organisations (SCVO) is a Scottish Charitable Incorporated Organisation. Registration number SC003558.

Regulator says no issues of concern after individual makes charity complaint

This news post is over 3 years old
 

Both Scottish and English regulators received complaint but found it had no basis

A complaint has been dismissed by the Charity Commission after an investigating concerning a clinical trial described as a “scandal”.

The complaint against the charity was made to both the commission and the Office of the Scottish Charity Regulator last month.

It concerned a PACE trial (Pacing, graded Activity, and Cognitive behaviour therapy; a randomised Evaluation) that the charity was involved with, which began in 2005 and cost more than £5m to deliver.

The results of the trial were published in the medical journal The Lancet in 2011, and recommended Graded Exercise Therapy as an effective intervention for the treatment of ME. However the results were subsequently discredited.

Part of the complaint against Action for ME, claims the charity “abused its charitable status” through its involvement in the “PACE trial scandal”.

The complaint alleged that the PACE trial was motivated by a desire to downplay and deny the disease by categorising it as psychological.

They also said the trial produced “false evidence for Cognitive Behavioural Therapy and Graded Exercise Therapy”, and that the involvement of Action for ME “caused detriment and harm” to sufferers of ME.

Action for ME denied endorsing the results of the medical trial. The charity said it has campaigned for many years against the consideration of ME as a psychological condition, and works closely with professionals and policy-makers to improve access to appropriate care and support services for people with the disease.

Action for ME confirmed the regulator had written to the charity’s trustees outlining its role to ensure that trustees are complying with and discharging their legal duties and responsibilities, and that the charity is managing any incident responsibly.

“The Charity Commission has responded to say that based on the information we have provided, the commission was assured that the trustees are dealing with the matter appropriately and responsibly, therefore no further action will be taken,” said the charity.

A commission spokesperson said: “We recently engaged with the charity Action for ME concerning its past participation in the PACE trial, including specifically whether this activity was within its charitable purposes.

“In response to this, the trustees provided us with comprehensive information about the charity’s involvement in this study and their subsequent handling of this issue.”

The commission concluded: “Based on this information, we did not identify any issues of concern for the commission or that their participation in the trial had been outside of their charitable purpose. Should further concerns come to light we would assess them.”

The Office for the Scottish Charity Regulator confirmed it had received the complaints alongside the commission.